| 2023-08-14 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 1,241 0.0019% | $138.16 | $171,455 | -13.1% | |
| 2023-02-06 | Vera Therapeutics, Inc. VERA | 1.71M 4.5707% | $7.00 | $12M | +91.54% | |||
| 2022-11-22 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 6,974 0.0109% | $150.45 | $1.05M | -10.74% | |
| 2022-08-05 | Sale | Jazz Pharmaceuticals plc JAZZ | 1,089 0.0017% | $152.33 | $165,883 | -6.46% | ||
| 2022-04-19 | Inozyme Pharma, Inc. INZY | 1.35M 2.811% | $3.69 | $5M | -33.04% | |||
| 2022-02-10 | Vera Therapeutics, Inc. VERA | 666,666 2.3189% | $15.00 | $10M | +3.03% | |||
| 2021-05-18 | Vera Therapeutics, Inc. VERA | 1.82M 15.4233% | $11.00 | $20M | +57.41% | |||
| 2020-11-12 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 9,929 0.018% | $146.72 | $1.46M | +11.79% | |
| 2019-08-09 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 726 0.0013% | $135.65 | $98,481 | -9.37% | |
| 2018-09-06 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 10,130 0.0167% | $168.76 | $1.71M | -19.03% | |
| 2018-08-10 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 1,365 0.0022% | $175.13 | $239,057 | -21.48% | |
| 2017-12-11 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 9,000 0.015% | $139.73 | $1.26M | +11.43% | |
| 2017-11-17 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 352 0.0006% | $133.19 | $46,883 | +16.53% | |
| 2017-08-25 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 351 0.0006% | $148.40 | $52,088 | +2.68% | |
| 2017-08-11 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 662 0.0011% | $142.37 | $94,248 | +4.2% | |
| 2017-03-16 | Sale | Corcept Therapeutics Incorporated CORT | director | 269,955 0.2406% | $9.94 | $2.68M | +57.39% | |
| 2017-03-15 | Sale | Corcept Therapeutics Incorporated CORT | director | 279,020 0.2479% | $10.24 | $2.86M | +51.71% | |
| 2017-03-14 | Sale | Corcept Therapeutics Incorporated CORT | director | 300,000 0.2679% | $10.01 | $3M | +55.14% | |
| 2017-03-13 | Sale | Corcept Therapeutics Incorporated CORT | director | 20,980 0.0192% | $11.13 | $233,491 | +42.62% | |
| 2017-03-08 | Sale | Corcept Therapeutics Incorporated CORT | director | 750,000 0.6665% | $9.75 | $7.31M | +55.81% |